(By Meghana Keshavan for STAT)
There hasn’t been a lot of innovation1 in the obesity drug market. Sure, a smattering of companies have come out with weight loss medications — but their results have been middling and their financial performance poor. Continue reading article here…..
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.